NCT07210502 - Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2030

Study Completion Date

December 1, 2030

Conditions

Prostate Adenocarcinoma

Interventions

RADIATION

4D Low Dose Rate Prostate Brachytherapy

Permanent implantation of radioactive seeds in the prostate gland which slowly deposit half their dose approximately every 60 days. Prescription dose 145 Gy.

RADIATION

Ultra-hypofractionated Radiotherapy

The prescription dose is 36.25 Gy given in 5 fractions over 1-2 weeks (i.e. daily or alternate daily at department discretion) delivered on linear accelerator

Trial Locations (1)

GU2 7XX

Royal Surrey NHS Foundation Trust, Guildford

All Listed Sponsors

lead

Royal Surrey County Hospital NHS Foundation Trust

OTHER